Regulation and function of mTOR signalling in T cell fate decisions
What this study shows
Review of mTOR signalling in T-cell fate decisions.
At a glance
| Evidence type | R Review — secondary literature, not a new result Marked R because it is a review or synthesis of existing evidence rather than a new primary result; that is a different form of writing, not a weaker one. |
| Study type | Narrative Review |
| Model system | Review |
| Journal | Nature reviews. Immunology |
| Year | 2012 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1038/nri3198 · PMID 22517423 · Free full text (PMC3417069) |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | Not applicable (review) |
| Target | mTOR / mTORC1 & mTORC2 |
| Model | Review |
| Effect | mTOR integrates immune and metabolic cues to program T-cell homeostasis, activation and differentiation |
In the Atlas
Related topics
More studies on this topic
- The kinase mTOR regulates the differentiation of helper T cells through the selective activation of signaling by mTORC1 and mTORC2 (2011)
- Enforcing mTORC1 activity in therapeutic CD4+ T cells promotes persistence but eventual immune exhaustion (2026)
- Amino acid homeostasis by CORVET/HOPS: A metabolic and stress resilience checkpoint for T cells (2026)
- The role of mTORC2/RICTOR in immune cells and inflammatory diseases. (2026)
Was this page useful?
Thank you. Your answer was counted anonymously.